James Burke

2 weeks ago | journals.plos.org | Samuel W. Terman |Hélène E. Aschmann |David Hutton |James Burke

In the Funding statement, the grant number from the funder Early Postdoc.Mobility Fellowship by the Swiss National Science Foundation is not indicated. The grant number is: 191414. Reference1. Terman SW, Aschmann HE, Hutton DW, Burke JF. Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PLoS One. 2023;18(3): e0282658.

Oct 20, 2023 | mdatl.com | James Burke |Haley Harward

An 82-year-old grandmother falls and cannot move her legs. A 33-year-old computer programmer with no medical problems suddenly develops severe back pain. A 24-year-old daycare worker suddenly cannot breathe. These are all patients with very different clinical scenarios but have one explanation. They are affected by acute thoracic aortic syndrome. In most cases, this syndrome is related to an undiagnosed thoracic aortic aneurysm.

Jul 21, 2023 | n.neurology.org | James Burke |Kevin Kerber |Kenneth M. Langa |Roger L Albin

AbstractLecanemab, a novel amyloid-sequestering agent, recently received accelerated FDA approval for the treatment of mild Dementia due to Alzheimer Disease (AD) and Mild Cognitive Impairment (MCI). Approval was based on a large Phase 3 trial, Clarity, which demonstrated reductions in amyloid plaque burden and cognitive decline with lecanemab.